
Efflux pump‐deficient mutants as a platform to search for microbes that produce antibiotics
Author(s) -
MolinaSantiago Carlos,
Udaondo Zulema,
Daddaoua Abdelali,
Roca Amalia,
Martín Jesús,
PérezVictoria Ignacio,
Reyes Fernando,
Ramos JuanLuis
Publication year - 2015
Publication title -
microbial biotechnology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.287
H-Index - 74
ISSN - 1751-7915
DOI - 10.1111/1751-7915.12295
Subject(s) - efflux , mutant , antibiotics , microbiology and biotechnology , chemistry , biology , biochemistry , gene
Summary P seudomonas putida DOT ‐ T 1 E ‐18 is a strain deficient in the major antibiotic efflux pump ( TtgABC ) that exhibits an overall increased susceptibility to a wide range of drugs when compared with the wild‐type strain. We used this strain as a platform to search for microbes able to produce antibiotics that inhibit growth. A collection of 2400 isolates from soil, sediments and water was generated and a drop assay developed to identify, via growth inhibition halos, strains that prevent the growth of DOT ‐ T 1 E ‐18 on solid L uria– B ertani plates. In this study, 35 different isolates that produced known and unknown antibiotics were identified. The most potent inhibitor of DOT ‐ T 1 E ‐18 growth was an isolate named 250J that, through multi‐locus sequence analysis, was identified as a Pseudomonas sp. strain. Culture supernatants of 250J contain four different xantholysins that prevent growth of G ram‐positive bacteria, G ram‐negative and fungi. Two of the xantholysins were produced in higher concentrations and purified. Xantholysin A was effective against B acillus , L ysinibacillus and R hodococcus strains, and the effect against these microbes was enhanced when used in combination with other antibiotics such as ampicillin, gentamicin and kanamycin. Xantholysin C was also efficient against G ram‐positive bacteria and showed an interesting antimicrobial effect against P seudomonas strains, and a synergistic inhibitory effect with ampicillin, chloramphenicol and gentamicin.